Eviosys
Eviosys has invested €8 million in expanding the capacity of production of two-piece cans in three factories: Alcochete (Portugal), Murcia and Ribadumia (Spain). The investment will support additional production, custom printing and expanded logistics capabilities at all the sites, supporting the demand Eviosys customers are seeing in the fish, meat and pet food markets.
ZUG, SWITZERLAND / ACCESSWIRE / September 15, 2023 / Championing the Eviosys principle of global leader and local partner, the giant in the sustainable packaging industry has invested €8 million in expanding the capacity of production of two-piece cans in three factories: Alcochete (Portugal), Murcia and Ribadumia (Spain).
An example of the products produced on Eviosys' new lines in Spain and Portugal
The investment comes as the growing need for two-piece and EOE round and irregular cans in aluminum and steel in the fish, meat and pet food markets continues to increase. The fish market alone has grown in demand, +3.8% in 2022[1], highlighting the need for a reliable, sustainable, and local packaging manufacturer.
Working closely with partners in Spain and Portugal, Eviosys has seen these highly dynamic markets, rapidly change with consumer trends. As the leader in the canned fish segment, Eviosys has taken proactive steps to ensure businesses in the regions are able to access all of their packaging needs to respond to these trends, supplying end consumers.
To support the additional production capabilities of the factories, investment has been directed into custom printing and bolstered logistics support, meaning Eviosys customers can holistically grow their product production and delivery.
As Eviosys continues to grow in 2023, this investment reinforces its leadership in the Iberian Peninsula. The expanded capacity will allow Eviosys to continue delivering the best level of service to local customers. Investing in solutions to always provide customers with the best services and to ensure they can grow is at the core of Eviosys' mission.
Tomás Lopez, Chief Executive Officer, Eviosys, said:
"Our investment in the region showcases our commitment to our core principle of being a global leader and local partner. In 2023 and beyond, we'll continue to grow with our partners in the region, supporting them in what is a dynamic, fast-moving market, ensuring they can deliver for their customers."
Notes to Editors
To request further information, images, or interviews, please contact: eviosys@grayling.com.
About Eviosys:
Eviosys is a leading global supplier of metal packaging, producing food cans and ends, aerosol cans, metal closures and promotional packaging to preserve the products of hundreds of consumer brands.
Eviosys has the largest manufacturing footprint in Europe, the Middle East and Africa (EMEA) with 6,700 employees in 45 manufacturing facilities across 18 countries. In 2022, it generated €2.7 billion in revenue. Eviosys is a portfolio company of KPS Capital Partners, LP.
For more information, visit www.eviosys.com.
[1] Shelf Stable Seafood (Source: Euromonitor)
Contact Information:
Maisie Jenyon
PR Manager
eviosysuk@grayling.com
SOURCE: Eviosys
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/784548/eviosys-announces-further-investment-in-spain-and-portugal-supporting-market-growth
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release
Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres
General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release
DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release
MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom